Table 3.
Survival of hub genes, high expression of MMP11, COL5A2, CDC25B, TOP2A, CENPF, CDCA3, TK1, TPX2, CDCA8, AEBP1, and FOXM1 were correlated with better overall survival of patients with bladder cancer.
| Gene | HR | LL | UL | P-value |
|---|---|---|---|---|
| MMP11 | 3.19 | 1.99 | 5.1 | 1.30E-06 |
| COL5A2 | 2.65 | 1.64 | 4.28 | 6.55E-05 |
| CDC25B | 2.58 | 1.49 | 4.45 | 0.0006656 |
| TOP2A | 2.46 | 1.44 | 4.18 | 9.57E-04 |
| CENPF | 2.42 | 1.4 | 4.19 | 0.0015458 |
| CDCA3 | 2.5 | 1.39 | 4.49 | 0.0021009 |
| TK1 | 2.05 | 1.29 | 3.25 | 0.002275 |
| TPX2 | 1.87 | 1.25 | 2.61 | 0.0024666 |
| CDCA8 | 1.99 | 1.26 | 3.12 | 0.0029615 |
| AEBP1 | 1.65 | 1.1 | 2.47 | 0.0148293 |
| FOXM1 | 2.27 | 1.09 | 4.74 | 0.0293848 |